论文部分内容阅读
目的探讨宫颈液基细胞学检测系统(LCT)联合阴道镜下组织病理学检查在农村妇女宫颈癌筛查中的临床价值。方法收集2009年10月至2011年8月参加宫颈癌筛查的8000例妇女行LCT检测,其中164例LCT细胞学阳性患者于阴道镜下取多点活组织病理细胞学检查。结果慢性宫颈炎66例,占40.2%,CINⅠ级45例,占27.4%,CINⅡ级26例,占15.9%,CINⅢ级16例,占9.8%,宫颈癌11例,占6.7%。其中ASC诊断符合率为70.7%(41/58),LSIL诊断符合率为57.9%(33/57),HSIL诊断符合率为55.9%(19/34),SCC诊断符合率为27.3%(3/11)。结论 LCT能准确反映宫颈病变,在妇女宫颈癌普查中有较高的临床应用价值;LCT联合阴道镜下多点活检,可明显提高对子宫颈病变诊断的准确性,能满足早期子宫颈癌及癌前病变筛查的需要。
Objective To investigate the clinical value of LCT combined with colposcopic histopathology in screening cervical cancer in rural women. Methods Eighty-eight women who underwent screening for cervical cancer from October 2009 to August 2011 were examined by LCT. 164 LCT-positive patients underwent colposcopic biopsy under colposcopy. Results Chronic cervicitis 66 cases, accounting for 40.2%, CIN Ⅰ 45 cases, accounting for 27.4%, CIN Ⅱ 26 cases, accounting for 15.9%, CIN Ⅲ 16 cases, accounting for 9.8%, cervical cancer in 11 cases, accounting for 6.7%. The coincidence rate of ASC diagnosis was 70.7% (41/58), LSIL diagnosis coincidence rate was 57.9% (33/57), HSIL diagnosis coincidence rate was 55.9% (19/34), SCC diagnosis coincidence rate was 27.3% (3 / 11). Conclusion LCT can accurately reflect the cervical lesions in the women’s cervical cancer screening has a higher clinical value; LCT combined with colposcopy multi-point biopsy can significantly improve the accuracy of the diagnosis of cervical lesions can meet the early cervical cancer and Need for precancerous screening.